Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06406621 · ClinicalTrials.gov registry record · NA

Pilot Trial Assessing the Effectiveness of Laser Hair Depilation on Pilonidal Disease Recurrence in Patients With Darker Skin Color

A NA study of Pilonidal Disease, sponsored by Nemours Children's Clinic.

Recruiting
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT06406621 is a NA study of Pilonidal Disease that is actively recruiting participants, run by Nemours Children's Clinic. The registered enrollment target is 36 participants, below the 142-participant average among 5 other Pilonidal Disease trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06406621, a NA study of Pilonidal Disease, is actively recruiting participants, sponsored by Nemours Children's Clinic.

RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

Pilot randomized trial assessing the effectiveness of laser hair depilation on pilonidal disease recurrence in patients with darker skin color

Conditions Studied

Interventions

  • PROCEDURE Laser hair depilation

Study Locations (1)

Delaware

  • Nemours Children's Hospital Delaware - Wilmington

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2025-10-01
Est. Completion 2027-09-30
Phase NA

Sponsor

Nemours Children's Clinic

108 total trials

What the Registry Record Tells You About NCT06406621

The ClinicalTrials.gov registry entry for NCT06406621 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 142-participant average among 5 other Pilonidal Disease trials with a reported enrollment target (75% lower). The listed sponsor is Nemours Children's Clinic, which has 108 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pilonidal Disease appearing as the primary indexed condition, and to 1 intervention - of which Laser hair depilation is the first listed.

NCT06406621 reports 1 study location spanning 1 distinct geographic area - top geographies include Delaware.

Frequently Asked Questions

What is clinical trial NCT06406621 about?

NCT06406621 is a clinical study titled "Pilot Trial Assessing the Effectiveness of Laser Hair Depilation on Pilonidal Disease Recurrence in Patients With Darker Skin Color". Pilot randomized trial assessing the effectiveness of laser hair depilation on pilonidal disease recurrence in patients with darker skin color

What is the current status of trial NCT06406621?

This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2025-10-01. Estimated completion is 2027-09-30.

What conditions does trial NCT06406621 study?

This clinical trial studies the following conditions: Pilonidal Disease.

What interventions are being tested in trial NCT06406621?

The interventions under investigation include: Laser hair depilation (PROCEDURE).

Who is sponsoring clinical trial NCT06406621?

This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06406621 being conducted?

This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pilonidal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.